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Gap junction protein Connexin-43 is a direct
transcriptional regulator of N-cadherin in vivo
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Alexandra Schambon 4 & Roberto Mayor1
Connexins are the primary components of gap junctions, providing direct links between cells
under many physiological processes. Here, we demonstrate that in addition to this canonical
role, Connexins act as transcriptional regulators. We show that Connexin 43 (Cx43) controls
neural crest cell migration in vivo by directly regulating N-cadherin transcription. This activity
requires interaction between Cx43 carboxy tail and the basic transcription factor-3, which
drives the translocation of Cx43 tail to the nucleus. Once in the nucleus they form a complex
with PolII which directly binds to the N-cadherin promoter. We found that this mechanism is
conserved between amphibian and mammalian cells. Given the strong evolutionary con-
servation of connexins across vertebrates, this may reﬂect a common mechanism of gene
regulation by a protein whose function was previously ascribed only to gap junctional
communication.
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Gap junctions are transmembrane complexes of connexinproteins that allow intercellular communication and thetransfer of ions and small signaling molecules between
adjacent cells1. In addition to their channel functions at the
plasma membrane, connexins can produce small fragments or
isoforms that are present in different cellular compartments
including the nucleus2 and thus may function in alternative
processes, such as gene expression3,4.
The mutual regulation in the assembly of gap and adherens
junctions5,6 suggests a possible coordination in the expression of
their constituent proteins. Collective cell migration, which is fun-
damental for morphogenesis and cancer invasion7, depends on
both gap and adherens junctions8. In mice, the gap junction pro-
tein Connexin 43 (Cx43) is essential for the formation of heart
structures like the conotruncus. This role is attributed to the
function of Cx43 in cardiac neural crest cells, which migrate to the
target tissue and contribute to heart development9,10. In many
systems, embryonic neural crest cells can undergo collective cell
migration7,11 and require a tight regulation of the expression of the
adherens junction protein N-cadherin12,13. Both N-cadherin and
Cx43 modulate cell migration14,15 and their interaction has been
furthered explored in mesenchymal cells, where Cx43 was shown
to modify the levels of N-cadherin at the cell membrane16. How-
ever, the mechanism driving this regulation remains unknown.
Here, we ask whether Cx43, one of the most widely studied gap
junction proteins, regulates N-cadherin expression during col-
lective cell migration and investigate the molecular nature of such
regulation. We show that Cx43, a molecule primarily known for
its membrane-linked activities, uses its tail isoform to control
morphogenetic movements via transcriptional regulation of N-
cadherin. This nuclear activity is independent of its function as
channel in the cell membrane. Moreover, we identify its
mechanism of action, showing that Cx43 regulation of N-
cadherin is due to a direct interaction with the basic transcription
factor 3 (BTF3). BTF3 is able to form a stable complex with
polymerase II and is part of the transcription initiation
complex17,18. In more recent studies, BTF3 upregulation has been
correlated with tumor prognosis19,20 and the transcriptional
activity of BTF3 has been implicated in proliferation and cancer
progression20,21. Here, we demonstrate that Cx43-tail, BTF3 and
Pol II altogether form a complex that directly binds to the n-cad
promoter to modulate N-cadherin transcription. Furthermore, we
show that this unexpected activity of Cx43 as a regulator of N-
cadherin is conserved between amphibian and mammalian cells.
Results
Cx43 promotes neural crest migration via N-cadherin regula-
tion. To examine the role of Cx43 in neural crest development,
we used antisense morpholino knock-down (Cx43MO). Deple-
tion of Cx43 impaired collective chemotaxis of Xenopus cephalic
neural crest (Fig. 1a, b; Supplementary Movie 1), without
affecting single cell motility (Fig. 1c; Supplementary Movie 2). On
the cellular level, we found that Cx43 is essential for cell mor-
phology and polarization (Fig. 1d, e). We next asked whether
downregulation of Cx43 affects expression of N-cadherin,
which induces cell polarity and is required for neural crest
migration11–13. Cx43MO led to a reduction in N-cadherin pro-
tein (Fig. 1f–i), whereas the levels of other junctional proteins
such as E-cadherin were unaltered (Fig. 1j–l). Analysis by QPCR
and in situ hybridization showed that Cx43MO decreased n-
cadherin at the mRNA level (Fig. 2a–c), The effects of Cx43MO
on neural crest migration (Fig. 2d, e), cell polarity (Fig. 2f, g),
protrusions (Fig. 2h, i), and cell dispersion (Fig. 2j, k) were res-
cued by co-expression of n-cadherin mRNA, showing N-cadherin
as the main Cx43 target in this process. Together these results
show that Cx43 promotes neural crest migration by controlling
N-cadherin levels.
Several experiments were performed to control for the
speciﬁcity of our antisense morpholino treatments. First, 8–24
ng of two different morpholinos were used and because they
generated identical efﬁciency and phenotypes (Fig. 3c), we show
the results of only one of them, hereafter referred as Cx43MO.
Second, efﬁciency of the morpholinos was determined by western
blot against Cx43 (Fig. 3a, b), whereas speciﬁcity was demon-
strated by rescue with Cx43 mRNA that does not bind the
morpholinos (Fig. 3c–e). In addition, we showed by grafting
experiments that Cx43 MO works in a cell autonomous manner
(Fig. 3f) and that speciﬁcally affect neural crest migration without
interfering with neural crest induction, as none of the early neural
crest markers are affected by Cx43MO (Fig. 3g). These
experiments show that Cx43MO is a speciﬁc inhibitor of Cx43
during neural crest migration.
Cx43 20k isoform controls cell migration via N-cadherin. It has
been shown in mammalian cells that Cx43 exists in two forms:
the full-length molecule (Cx43FL), which is a component of gap
junctions, and smaller carboxy-terminal fragments, being the
most abundant the isoform of 20 kDa (Cx43-20k)22,23. These
isoforms are present in many cell systems and their function
remains unclear. We determined the presence of Cx43 isoforms
in Xenopus neural crest and examined their temporal expression
during development. Cx43FL was expressed at similar levels
throughout the developmental stages analyzed, whereas expres-
sion of shorter Cx43 isoforms, in particular Cx43-20k, increased
just before the onset of neural crest migration (Fig. 4a, b, stage 18
onwards), and we conﬁrmed that these Cx43 isoforms are present
in neural crest cells (Fig. 4c).
To test the effects of the Cx43-20k on N-cadherin regulation
we selectively over-expressed constructs containing or lacking the
20k fragment (Cx43-20k or Cx43Trun, respectively, Fig. 4d).
Expression of Cx43-20k led to upregulation of N-cadherin mRNA
in Xenopus cells (Fig. 4e–g). Reduction of n-cadherin expression
and neural crest migration by Cx43MO can be rescued by
Cx43FL or Cx43-20k, but not by Cx43Trun (Fig. 4h–l). In
addition, Cx43 was coexpressed with N-cadherin in migrating
neural crest (Fig. 5a) and the increase in Cx43-20 levels matched
those in n-cadherin expression (Fig. 5b). These results indicate
that the Cx43-20k contains the activity that controls N-cadherin
expression and neural crest migration.
Next, we asked how this isoform is generated. Consistently
with ﬁndings in mammalian cells22–24, analysis of the Xenopus
Cx43 sequence show several putative internal ribosome entry site
(IRES) (Fig. 5c); however, the major Cx43 isoform observed
correspond to the 20 kDa peptide (red arrow in Fig. 5d). The
Cx43-20k fragment contains two putative IRES (M213 and
M279) with predicted sizes for the respective polypeptides of 20
and 11 kDa (Fig. 5c). However, expression of the Cx43-20k
fragment in Xenopus embryos only generates a peptide of 20 kDa
(Fig. 5e). Furthermore, expression of the Cx43-20k, but not the
Cx43-11k, leads to N-cadherin upregulation (Fig. 5f). To further
demonstrate that the Cx43-20k isoform is generated by internal
translation we showed that mutation of the M213 blocks the
production of Cx43-20k (Fig. 5g, h). Consistently with observa-
tions performed in mammalian cells24, we observed that the
production of Cx43-20k in neural crest cells depends on hypoxia,
since the levels of Cx43-20k are reduced or increased during
inhibition or activation of the hypoxic factor Hif1α (Fig. 5i, j).
Importantly, Hif pathway has been previously shown to be
required for neural crest migration25. Together, these data show
that like in mammalian cell22–24, Cx43-20k is produced by the
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internal translation site M213 generating a 20 kDa peptide that is
able to control N-cadherin expression.
We show that the presence of Cx43-20k is conserved across
species as it is present in mammalian HeLa cells (Supplementary
Fig. 1a) and is able to upregulate N-cadherin levels in HeLa cells
(Supplementary Fig. 1b–d) and in amphibian XTC cells (Supple-
mentary Fig. 1e). In addition, inhibition of Cx43 channel activity by
two gap junction blockers (F.F.A. and M.F.A.) did not affect N-
cadherin expression (Supplementary Fig. 1f–k). Together, these
results suggest a role for Cx43-20k in controlling N-cadherin
expression and cell migration independent of Cx43 channel activity.
Cx43-20K isoform is a transcriptional regulator of N-cadherin.
To understand the underlying cellular mechanism of this
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transcriptional regulation, we investigated the subcellular locali-
zation of Cx43 and Cx43-20k. We observed that Cx43-20k, but
not Cx43Trun, localizes in the nucleus of HeLa (Fig. 6a) and
neural crest cells (Supplementary Fig. 2a). Furthermore, an
antibody that recognizes the carboxy terminal of Cx43 revealed
nuclear localization in neural crest (Supplementary Fig. 2b), HeLa
cells (Supplementary Fig. 2c) and XTC cells (Supplementary
Fig. 2d). This result was conﬁrmed by subcellular fractionation of
Xenopus embryos, where Cx43-20k was detected in the nuclear
fraction (Supplementary Fig. 2e). To investigate if the nuclear
localization of Cx43 is required for N-cadherin expression and
cell migration, we fused the binding domain of the human glu-
cocorticoid receptor (GR) with GFP-tagged Cx43-20k (Cx43-
20kGR-GFP; Fig. 6b). This construct entered the nucleus of
neural crest and HeLa cells only in the presence of dex-
amethasone (dxm)26 (Fig. 6c, i). Inhibition of n-cadherin
expression (Fig. 6d–f) and cell migration (Fig. 6g, h) induced
by Cx43MO was rescued in embryos injected with Cx43-20kGR-
GFP after dxm treatment (Fig. 6d–h). These results suggest that
the nuclear localization of Cx43-20k is required for N-cadherin
regulation and that this regulation is conserved across different
cell types.
We next explored the role of Cx43-20k on N-cadherin
regulation. It is possible that Cx43-20k controls n-cadherin
mRNA levels by regulating transcription or mRNA degradation.
We found no difference in the rate of n-cadherin mRNA
degradation between CTLMO and Cx43MO embryos (Fig. 7a–c),
indicating that Cx43 does not regulate mRNA stability. To test
whether Cx43-20k controls N-cadherin without the need of
translation of other genes, we blocked protein synthesis using the
translation inhibitor cycloheximide (CHX). Cx43-20kGR-injected
embryos treated with CHX, followed by dxm addition, showed an
upregulation of N-cadherin expression, similar to non-CHX
treated embryos (Fig. 7d, e), suggesting a direct effect of Cx43-20k
on n-cadherin transcriptional regulation.
Cx43-20k isoform interacts with the transcription factor BTF3.
To further explore the mechanisms underlying N-cadherin reg-
ulation and translocation of Cx43-20k isoform to the nucleus, we
performed mass spectrometry analysis of Hela cells transfected
with Cx43-20k construct. Using 1.3-fold change as a minimal cut-
off for consideration between immunoprecipitated (IP) and
control samples27, we found 30 candidates that are nuclear pro-
teins and interact with Cx43-20k (Fig. 7f), reﬂecting potential
binding partners that may be involved in N-cadherin regulation.
Examination of the Xenopus database (Xenbase) revealed that
these 30 candidates are expressed in Xenopus laevis but only one
is speciﬁcally expressed in migrating neural crest cells (Fig. 7f, g):
the BTF318,28,29. To test its possible function, we designed a
BTF3MO and found that it inhibited neural crest migration and
n-cadherin expression, similar to Cx43MO, and both phenotypes
are rescued by full length BTF3 mRNA (Fig. 8a–d). BTF3MO
decreased endogenous BTF3 levels (Supplementary Fig. 3a), and
did not affect neural crest induction (Supplementary Fig. 3b). Co-
injection of BTF3MO with Cx43-20k blocked the effects of Cx43-
20k alone on n-cadherin expression (Fig. 8e, f) and nuclear
localization of Cx43-20k (Fig. 8g), indicating that BTF3 is
required for Cx43-20k activity. On the other hand, inhibition of
Cx43 by Cx43MO did not affect the nuclear localization of BTF3
(Supplementary Fig. 3c), suggesting that BTF3 localizes to the
nucleus even in absence of Cx43, whereas Cx43 requires BTF3 to
mediate its subcellular localization. These observations are con-
sistent with the presence of a nuclear localization signal (NLS) in
BTF330 and its absence in Cx43-20k. Indeed, expression of an
NLS-depleted BTF3 construct failed to rescue Cx43-20k nuclear
localization (Fig. 8h). Knock-down of BTF3 in mammalian cells
(Fig. 9a, b) also impaired Cx43-20k nuclear localization (Fig. 9c,
d) and blocked N-cadherin expression induced by Cx43-20k
(Fig. 9e, f), arguing for a conserved role of BTF3 and Cx43-20k.
Altogether these data show that Cx43-20k is translocated to the
nucleus via the NLS domain of BTF3 to control N-cadherin
expression in amphibian and mammalian cells.
As both BTF3 and Cx43 are localized in the nucleus (Fig. 10a)
and BTF3 NLS is required for Cx43-20k nuclear translocation, we
hypothesized a direct interaction between these proteins. To test
for physical interaction between Cx43-20k and BTF3 in the
nucleus, we used bimolecular ﬂuorescence complementation
system (BiFC), in which two VENUS components (VC and
VN9m) form a ﬂuorescent protein when brought into close
apposition31. To build the BiFC system we fused the VENUS
component (VC) to either Cx43-20k or Cx43Trunc, while the
other VENUS component (VN9m) was fused to BTF3. Empty VC
was used as a control. Cx43-20kVC co-injected with BTf3VN9m
gave a positive signal not observed with other combinations
(Fig. 10b). Moreover, this signal was higher in the nucleus
(Fig. 10c). These data support a direct interaction between Cx43
and BTF3 in the nucleus.
Cx43-20k isoform and BTF3 binds to n-cadherin promoter. To
verify the biochemical interaction of Cx43-20k and BTF3, we
performed co-immunoprecipitation (IP). We found that endo-
genous Cx43-20k and BTF3 co-precipitate in Hela cells (Fig. 10d).
Our experiments also conﬁrmed that BFT3 interacts with poly-
merase II (Pol II; Fig. 10e), as previously shown17. These results
support the notion that three proteins, Cx43Tail, BTF3 and Pol II,
interact and may function as a transcriptional complex in the
promoter of n-cadherin. To test this possibility, we performed
chromatin immunoprecipitation (ChIP). We examined whether
endogenous Pol II binds to the promoter of n-cadherin in
the presence or absence of Cx43, by performing PCR against the
Fig. 1 Cx43 controls NC migration via N-cadherin regulation. a Neural crest chemotaxis towards SDF-1. Scale bar= 100 μm. b Chemotaxis index (nCMO: 40,
nCxMO:45 explants; N= 3). c Directionality and velocity of stage 23 (st23) single neural crest cells. Neural crests were dissected and dissociated as
described in Methods, followed by time-lapse imaging and tracking of individual cells (nCMO: 110, nCxMO: 115 cells, N= 4), related to Supplementary
Movie 1. d Neural crest cell morphology as visualized by life-actin-GFP (arrows mark normal and arrowheads irregular protrusions) and by immunostaining
for α-tubulin. e Cell morphology quantiﬁcation (nCMO= 58, nCxMO= 39, N= 3) and diagram: control cell is shown in blue and Cx43 morphant in yellow.
f N-cadherin (NCad) immunostaining of st23 neural crest. g Quantiﬁcation of N-cad across the cell contact of st23 neural crest. N-cad levels, 0 represents
contact point (nCTLMO= 25 and nCx43MO= 45 explants, N= 3). h Western blot (WB) of st23 embryo lysates for N-cad and Mapk. i N-cad levels
normalized to MAPK (nCMO: 156, nCxMO: 128 embryos, N= 5). j E-cadherin (ECad) immunostaining of st23 neural crest. k Quantiﬁcation of E-cad across
the cell contact of st23 neural crest cells. E-cad levels, 0 represents contact point (n: 13 explants, N= 3). Scale bars in d, f, and j= 20 μm. l WB of st23
embryo lysates for E-cad and Mapk. Box plots in b and e show the median, box edges represent the 25th and 75th percentiles, and whiskers show spread of
data including outliers (Mann Whitney test p*** < 0.001) and histograms in c, i mean ± SE (two-tailed t test p** < 0.01). Lines in g and k show mean and
error bars represent SD (two-tailed t test p*** < 0.001). N number of independent experiments; n sample size. Spread of data in bar charts is shown as
overlying dots. n.s. nonsigniﬁcant
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analyzed by in situ hybridization ISH against n-cad, arrowheads indicate normal and bracket decreased expression, white arrow injected side and green
segmented line the NC. c % of n-cad expressing embryos shown in b (nCMO= 178, nCxMO= 187 embryos, N= 9). d St23 embryo showing neural crest
migration by ISH for twist; normal (arrow) and impaired (brackets) migration and e % of st23 embryos with normal neural crest migration (nCMO= 89,
nCxMO= 105, nCxMO-ncad= 124 embryos, N= 3). Scales bar in b and d= 50 μm. f St23 neural crest cells expressing nRFP+mRFP; normal (arrows) and
short protrusions (arrowheads) and g cell morphology quantiﬁcation (nCMO= 86, nCxMO= 87, nCxMO-ncad= 98 cells, N= 3); Scales bar in f and h= 15 μm.
h St23 neural crest cells expressing nRFP+mRFP; in magenta lamellipodia extensions and i quantiﬁcation of protrusion area, (nCMO= 37, nCx43MO= 33,
nCxMO-ncad= 38 cells, N= 3). j Cell dispersion analysis after 6 h of culture using Delauney triangulation and k its quantiﬁcation (n= 10 NC explants, N= 3).
Histograms in a, c, e, i, and k represent mean ± SE (two-tailed t test p** < 0.01, p*** < 0.001). In g box plots show the median, box edges represent the 25th
and 75th percentiles, and whiskers show spread of data including outliers (Mann Whitney test p*** < 0.001). N number of independent experiments;
n sample size. Spread of data in bar charts is shown as overlying dots. n.s. nonsigniﬁcant
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n-cadherin promoter region of CTLMO and Cx43MO ChIP sam-
ples (Supplementary Fig. 4). We detected Pol II enriched at the n-
cadherin promoter in CTLMO ChIP samples, whereas this
enrichment was four times lower in ChIP samples collected from
Cx43MO-injected embryos (Fig. 10f). These results show that Cx43
is required for Pol II to bind at the n-cadherin promoter region. To
test whether Cx43-20k is recruited to the n-cadherin promoter, we
performed ChIP using Cx43-20kGFP or GFP (as a negative control)
on embryonic lysates. ChIP-PCR analysis showed that Cx43-20k
was enriched by three folds at the n-cadherin promoter region
(Fig. 10g). Therefore, we propose that Cx43-20k together with BTF3
and Pol II form a complex that controls the transcriptional activity
of n-cadherin at its proximal promoter.
Discussion
Although it was formerly speculated that connexin proteins may
control gene transcription2–4, there was no direct evidence that
this occurred and any underlying molecular mechanism remained
unknown. Our results are consistent with previous studies
showing that connexin fragments are found within the nucleus4,
and that inhibition of connexins have signiﬁcant effects on cell
differentiation2–4. In previous studies, it has been proposed that
the generation of these connexin fragments is controlled by the
PI3K/AKT/mTOR pathway in mammalian cells22, the Mnk1/2
pathway in various cancer cell lines23 and hypoxic conditions24. It
is plausible that similar mechanisms are at play in our system.
Indeed, in neural crest, the PI3K/AKT/mTOR pathway is
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present32,33 and could, therefore, be implicated for the generation
of connexin fragments. In our study, we show that Cx43 frag-
ments appear at the onset of neural crest migration which coin-
cide in time and space with the activity of Hif-1α (hypoxia-
inducible transcription factor-1), which is known to regulate
neural crest migration25. Indeed, our data show that the gen-
eration of Cx43 isoforms is regulated by Hif-1α in embryonic
Xenopus neural crest, similar to mammalian24.
Here, we show that these connexin fragments directly regulate
n-cadherin expression. In mesenchymal cells it has been shown
that Cx43 and N-cadherin regulate reciprocally each other’s levels
on the cell surfaces and it has been postulated that N-cadherin
and Cx43 share similarities in their regulatory pathways16. Such
regulation was mainly attributed to their functions at the cell
membranes16,34. Our results show that Cx43 controls the tran-
scription of N-cadherin, which in turn is required for directional
cell migration and cell polarization, a ﬁnding that is consistent
with known activities of Cx43 in cardiac neural crest in mice14,15.
Here, we show that Cx43, independent of its regulation on the
cell membrane, via its small isoform that localizes at the nucleus
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directly affects n-cadherin transcription. It is tempting to spec-
ulate that Cx43 may control expression of other genes, in other
cell types. Former in vitro studies have proposed an indirect role
for Cx43 in gene regulation, such as with members of the CCN
family or Smads31,35–37. Our data demonstrate that the carboxy-
terminal fragment of Cx43 plays a direct role as a transcriptional
regulator of gene expression in vivo. Several transcription factors
have been shown to regulate n-cadherin gene expression such as
FoxD338 or factors from Sox family, which bind to the enhancer
regions of n-cadherin gene39. Gene regulatory networks for the
neural crest place N-cadherin downstream of these transcription
factors40, and our results place Cx43 as an additional regulator of
n-cadherin in the neural crest gene regulatory network.
Here, we show that the transcription factor BTF3 binds to the
promoter region of n-cadherin41 with the help of Cx43 and
together positively regulate n-cadherin expression. Thus, BTF3, a
transcription factor previously associated with gene expression in
cancer systems20,21, regulates embryonic gene expression in
neural crest, a cell population that has been likened to cancer
cells42. Cx43 has been postulated to be upregulated in later stages
of neural crest development40 as in several cancer systems43,44, in
order to modulate cell migration. Here, we provide evidence that
three components associated with embryonic and cancer cell
biology are part of a common pathway, an adhesion molecule (N-
cadherin), fragments of another adhesion molecule (Cx43) and a
transcription factor (BTF3).
In summary, we have identiﬁed an original pathway by which
an adherens junction component, n-cadherin, is regulated by a
protein normally associated with a gap junctional communica-
tion. This opens the possibility of cross-talk between processes
mediating intercellular communication and cell–cell interaction,
unveiling a mechanism of cross-regulation between gap and
adherens junctions at the transcriptional level. The high con-
servation of Cx43 across different taxa and the presence of
Cx43Tail in various vertebrate systems may reﬂect an evolu-
tionary conserved mechanism of gene regulation by a protein
previously well-known by its gap junction activity.
Methods
Embryo manipulation. Adult X. laevis were maintained at 17 °C and used
according to the regulations of the Biological Service Unit at University College
London, complying with the UK Home Ofﬁce guidelines established in the Ani-
mals Act 1986 as described45. X. laevis embryos were obtained and staged as
previously described46,47. To speciﬁcally target the neural crest, embryos were
injected into the animal ventral blastomeres at the eight-cell stage on one side for
all experiments, except when embryonic lysates were used. In this case embryos
were injected in both animal sides of two-cell stage embryos. Embryo micro-
injections were performed according to48. If required, ﬂuorescein-dextran (FDx;
Invitrogen, D1821, 20 ng) or rhodamine-dextran (RDx; Invitrogen, D1824, 20 ng)
were used as tracers. Oligomorpholinos against X. laevis Cx43 (Cx43MO1; 8–24 ng,
5′-TTCCTAAGGCACTCCAGTCACCCAT-3′, Cx43MO2; 8–24 ng, 5′-
AAAAATGGTTTTCTTGTGGGTCGA-3′) and BTF3 (BTF3MO, 40 ng, 5′-
AACGGACCGGGTTTAAAGGCTTCCT-3′) were synthesized and provided by
Gene Tools LLC. Equimolar concentrations of standard control morpholino
(CTLMO: 3′-ATATTTAACATTGACTCCATTCTCC-5′) were used. The amounts
of morpholinos correspond to the amounts injected in one side of eight-cell stage
embryos, while the other side was used as an internal control. When embryos were
used for collection of embryonic lysates, they were injected at two-cell stage in both
animal blastomeres and double of the mentioned dosages were used. To test the
efﬁciency of Cx43MOs on the endogenous cx43 mRNA, we performed western blot
analysis. Both Cx43MOs efﬁciently lowered the protein levels of the endogenous
Cx43FL and Cx43iso (Fig. 3a, b). In order to validate BTF3MO efﬁciency, we tested
by immunostaining of neural crest cells the BTF3 protein expression, which
showed decreased levels of BTF3 in BTF3MO cells compared to CTLMO (Sup-
plementary Fig. 3a).
In situ hybridization was performed as previously described49,50. Brieﬂy,
embryos were ﬁxed in MEMPFA, followed by overnight hybridization with
digoxigenin-labeled probes, incubated with an AP antibody and AP activity was
developed using NBT/BCP substrates. Digoxigenin-labeled RNA probes were
prepared for foxD348 snail251, twist52, n-cadherin53, C353, btf3 (Xenbase:
XL075i22), and sox1054, sox954. C3 (1 μg/ml), snail2 (0.8 μg/ml), foxD3 (2 μg/ml),
sox10 (1 μg/ml), sox9 (1 μg/ml), and twist (0.7 μg/ml) were used to assess neural
crest induction, twist (0.7 μg/ml) for neural crest migration, n-cadherin (1 μg/mL)
to assess expression levels and btf3 (0.7 μg/mL) expression pattern. Whole-mount
immunostaining was carried out as previously described55 using Cx43 antibody
(1:1000, Sigma, C6219). Brieﬂy, embryos were ﬁxed in MEPMFA and incubated
overnight with the antibody at the described dilution.
Animal cap explants were dissected from Xenopus blastulas (stage 8) using a
standard technique48,56 and prepared for in situ-hybridization as described above.
For animal cap assays, 500 pg mRNA was injected into the animal side of the two
blastomeres of two-cell stage embryos. Analysis of ISH was performed on 20–25
embryos per condition for each independent experiment.
Neural crest manipulation and imaging. Neural crest transplants were carried out
as previously reported57. Brieﬂy, neural crest taken from stage 18 ﬂuorescently
labeled embryos were dissected with eyebrow knives and grafted into unlabeled host
embryos. For in vitro experiments, cranial neural crest explants were dissected at
stage 18 using a standard technique58,59 and plated on ﬁbronectin (Sigma, F1141)
coated dishes as previously described53. For single cell assays, neural crest cells were
brieﬂy dissociated in Ca2+/Mg2+-free Danilchick medium53. For each condition,
ten embryos transplanted with ﬂuorescent labeled NC were analyzed per experiment.
Immunostaining was performed on neural crest explants as previously
described54 using anti-N-cadherin (1:50, rat IgG, clone MNCD2, DSHB), anti-E-
cadherin (1:250, mouse IgG, clone 5D3, DSHB), anti-BTF3 (1:100, Abcam,
ab107213), anti-rabbit IgG Alexa488 (1:500, Invitrogen, A11034) and anti-rat IgG
Alexa488 (1:500, LifeTechnologies). When required, 4′,6- diamidino-2-
phenylindole (DAPI; 1 μg/mL, Sigma, D9542) and/or phalloidin
tetramethylrhodamin-b-isothiocyanate (PhR; 1 μg/mL, Sigma, P1951) were used.
Imaging of ﬁxed embryos was performed using a MZFLIII Leica ﬂuorescence
stereomicroscope equipped with a DFC420 Leica camera controlled by Leica
IM50 software. Imaging of in vitro neural crest migration was performed using
time-lapse cinematography as described previously53,60. Brieﬂy, neural crest cells
were cultured in plastic or glass petri dishes coated with ﬁbronectin, and time-lapse
microcopy was started after one hour of in vitro culture. For cell motility and
migration, compound microscopes (either an Eclipse 80i Nikon microscope with a
Hamamatsu Digital camera or a DMRXA2 Leica microscope with a Hamamatsu
Digital camera controlled by Simple PCI program) equipped with motorized stages
and a 10×/0.30NA dry lens were used. NC cultures were prepared as described
above. Images were acquired every 5 min for a period of 12 h. For cell morphology
imaging, a TCS SP8 microscope with a 63 × /0.90NA water immersion objective
lenses and controlled by LAS–AF software was used. Fixed cells were imaged using
a 63 × /1.4NA oil immersion objective and a Leica TCS SPE confocal microscope
controlled by LAS–AF software.
Fig. 5 Cx43-20 kDa isoform is generated from Internal Ribosome Entry Site (IRES). a twist ISH lcompared with Cx43 immunostaining in stage 24 embryos;
IgG control antibody; arrow: neural crest; asterisk: eye. Drawing: Cx43 and twist expression summary. Scale bar= 80 μm. b Cx43-20k protein levels
(analyzed by WB) and N-cadherin mRNA (analyzed by qPCR) in st23 NC cells (n= 61 embryos, N= 3). c–h Cx43 putative IRES and activity of Cx43
isoforms. c Predicted methionine-initiated polypeptide. Green: constructs used in e. Red arrows: abundant peptides found in Xenopus; gray arrows: less
abundant or absent peptides in Xenopus. d WB of embryos at NC migratory stages with antibody against the Cx43 C-terminus. Major bands correspond to
Cx43FL and Cx43-20k (arrows). eWB of neural crest expressing the Cx43-20k-HA with an antibody against HA. The only band generated corresponds to
the M276-initiated peptide (Cx43-20k). f Injection of Cx43-20k, but not Cx43-11k, leads to induction of N-cadherin expression in blastula embryos;
percentage of embryos displaying N-cadherin expression, (nCx43-11k= 20 embryos nCx43-20k= 20 embryos, N= 3). Scale bar= 70 μm. g WB against Cx43
from embryos at st21 injected with Cx43-HA (lane 1) and with Cx43 mutated in methionine 213 (M213L Cx43, lane 2). h WB’s quantiﬁcation (nlane1= 20
embryos nlane2= 20 embryos, N= 4). i WB of st22 neural crest cells with antibody against the Cx43 C terminus. Lane1: control neural crest; lane 2: neural
crest injected with Hif-1α morpholinos; lane 3: neural crest expressing a dominant active form of Hif-1α. j Quantiﬁcation of Cx43 isoforms (ncontrol= 50;
nHif-1αMO= 50; nHif-1αΔ= 50 neural crests, N= 6 independent experiments). Hif-1αMO and Hif-1αΔ were previously validated25. In f, h, and j histograms
represent mean and bars show s.e.m. (in j one-way ANOVA p < 0.001, two-tailed t test, p** < 0.01, p*** < 0.001, p**** < 0.0001). N number of independent
experiments; n sample size. Spread of data in bar charts is shown as overlying dots
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For construct localization or endogenous IF levels, 10–15 NCCs were analyzed
for each condition per experiment.
Cell migration and cell morphology analysis. Chemotaxis assay was performed
following a standard procedure61 using heparin acrylic beads (Sigma, H5263)
coated with 1 μg/mL puriﬁed human stromal cell-derived factor-1 (Sigma,
SRP3276). Cell motility and chemotaxis were analyzed using ImageJ (https://
imagej.nih.gov) analysis tools, as described previously53,60. Brieﬂy, each individual
cell was manually tracked using the Manual Tracking plugin of ImageJ, the data
were collected and analyzed using the Chemotaxis plugin of ImageJ. Cell mor-
phology was assessed by deploying the circularity index (complete circle= 1) and
estimated by ImageJ analysis tools. Cell dispersion was analyzed using Delaunay
triangulation algorithm (ImageJ Plugins) and was plotted as average explant tri-
angle area, as described before54. Cell protrusive area was analyzed in neural crest
cells at the edge of an explant measuring the outgrowing area that derives from two
consecutive timeframes with 4 min time interval; these two consecutive frames
were subtracted to generate the new area12. For analysis of cell chemotaxis and cell
dispersion 10–15 explants were analyzed per condition for each independent
experiment. For cell motility, cell morphology and cell protrusions 15–25 NCCs
were analyzed per condition per experiment.
Molecular biology, plasmids, and reagents. For cDNA synthesis, total RNA was
isolated from 10–15 embryos stages 23–24 or 10–15 animal caps stage 8 from X.
laevis per condition for each independent experiment and three technical replicas
were used within each experiment25. Quantitative PCR (qPCR) was performed on
an Applied Biosystems ABI 7900HT machine using the Fast SYBR Green Master
Mix (Applied Biosystems, 4385612) and the following primers: ef-1 forward 5′-
ACCCTCCTCTTGGTCGTTT-3′, ef-1 reverse 5′-TTTGGTTTTCGCTGCTTTC
T-3′15, ncad forward 5′-CAGGGACCAGTTGAAGCACT-3′, ncad reverse 5′-
TGCCGTGGCCTTAAAGTTAT-3′62. n-cad mRNA expression was plotted as
relative expression normalized against the housekeeping gene ef-1.
Plasmids: Cx43 constructs were synthesized using the X. laevis Cx43 sequence
from cDNA clone (UniGene ID XL.1109) as template. Full length Cx43 (Cx43FL,
aa 1–379), Cx43 carboxy terminally truncated construct (Cx43Trunc, aa 1–212)
and Cx43-20k construct (Cx43Tail, aa 213–379) were cloned into 5′BamHI/3′XhoI
of pCS2+ or pCS2-EGFP vectors. The pCS2-EGFP vector was kindly provided by
Dr. Masa Tada. Inducible construct of Cx43Tail was prepared by fusing the Cx43-
20kTail (aa 219–379) to the ligand-binding domain of the human GR (aa 512–777).
Cx43-20k was cloned into 5′EcoRI/3′SacI and GR into 5′SacI/3′XhoI of pCS2+
and pCS2-EGFP. BTF3 constructs were synthesized using the X. laevis sequence
from cDNA clone (UniGene ID XL.3536). BTF3FL (aa 1–162) was cloned into 5′
EcoRI/3′XhoI of pCS2+ or pCS2-EGFP. BTF3 deletion construct lacking the NLS
region RRKKK (BTF3-dNLS, aa 1–158) was cloned into 5′BamHI/3′ClaI of
pCS2+. For the BiFC experiments (Fig. 4b, c), Cx43Tail and Cx43Trunc were
cloned into 5′BamHI/3′BamHI of pCS2-VC155. BTF3FL was cloned into 5′
BamHI/3′BamHI of pCS2-VN9m. BiFC vectors were kindly provided by Prof
James C. Smith. All construct sequences are veriﬁed by automated DNA
sequencing (Source Biosciences, UK). When required, plasmids were linearized and
mRNA transcribed as described before25, using sp6MessageMachine (Ambion).
The mRNA constructs injected were: membrane GFP (mGFP, 300 pg),
membraneRFP (mRFP, 300 pg) nuclearRFP (nRFP, 300 pg), lifeactin-GFP (400 pg),
N-cadherin-GFP (500 pg), Cx43FL (500 pg), Cx43Trunc (500 pg), Cx43-20k
(500 pg), BTF3FL (500 pg), BTF3-dNLS (500 pg), Cx43-20k-VC (500 pg),
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Cx43Trunc-VC (500 pg), and BTF3-VN9m (500 pg). The following plasmids were
injected as DNA: pcDNA3.2-Cx43-HA (800 pg/embryo,22); pcDNA3.2-Cx43-ML-
HA (800 pg/embryo;22); ΔΜ213 Cx43 (800 pg/embryo,63).
All analysis on ﬂuorescent constructs was assessed by normalizing to the
background ﬂuorescence and when required, to total cell area ﬂuorescence.
The following reagents were used: ﬂufenamic acid (50 μM for NC explant
incubation −100μM for embryo treatment, Sigma, F9005), meclofenamic acid (50
μM for NC explant incubation −100μM for embryo treatment, Sigma, M4531),
actinomycin D (20 μM, Sigma, A1410), CHX (10 μM, Sigma, C7698) and ethanol-
dissolved dexamethasone (10 μM) was added to the culture medium at stages
14–15 and maintained until neural crest migratory embryonic stages (stage 23). To
control the possible leakage of inducible chimeras, a sibling batch of embryos were
cultured without dexamethasone and processed for in situ hybridization. For
coupling test (testing gap junction channel activity), 10–15 NCCs were analyzed
per condition per experiment.
Immunoprecipitation, fractionation, and western blotting. For each condition
10–15 embryos were used for preparation of embryo lysates per experiment. Whole
embryos were prepared for western blot after homogenization in lysis buffer
(20mM Tris, 100mM NaCl, 0.01% Triton-X, pH 8.0) with added protease inhi-
bitors (Roche, 11836153001) and phosphatase inhibitors (Roche, 04906837001)54,64.
For western blots, the following antibodies were used: Connexin 43 (Sigma, C6219,
1:1000), N-cadherin (DSHB, clone MNCD2, 1:800), E- cadherin (DSHB, clone 5D3,
1:1000), p42/44 MAPK (Cell Signaling, 9102S, 1:2000), α-tubulin (DSHB, clone
12G10, 1:1000), phospho-histone H3 (Millipore, 06579, 1:2000), GFP (Invitrogen,
A11122, 1: 2000), HA-tag (Sigma H6908, 1:2000), rabbit IgG HRP-linked (Amer-
sham ECL, NA934, 1:3000), mouse IgG HRP-linked (Amersham ECL, NA931,
1:3000) and rat IgG HRP-linked (Sigma, A9037, 1:2000). Immunoprecipitation was
performed using GFP-Trap® kit (Chromotek); brieﬂy, cells were suspended in lysis
buffer and centrifugated at 20,000×g for 5 min at 4 °C, the supernatant was
recovered and the volume adjusted with dilution buffer. Beads were equilibrated in
dilution buffer and mixed with the resuspended cell lysate. The mix was magneti-
cally puriﬁed and prepared for western blot. Nuclear fraction isolation of X. laevis
embryos was performed using differential centrifugation protocols with
modiﬁcations64,65. Brieﬂy, stage 18 X. laevis embryo lysates using a 22 G needle and
20 μL homogenization buffer (HB: 250mM sucrose, 20 mM Hepes, 10 mM KCl,
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in e as % of embryos expressing n-cad analyzed by ISH at blastula stage embryos (nCTL= 35, nCx43-20kGR= 46, nCx43-20kGR+dxm= 55, nCTL+cyc= 65,
nCx43-20kGR+cyc= 57, nCx43-20kGR+dxm+cyc= 64, N= 3). f Summary of mass spectrometry results to identify Cx43-20kD binding partners. Left: Pie chart of
Cx43-20 kD interactants. Right: Venn diagram of interactants found in nucleus. The Cx43-20kD binding partner shown in green corresponds to BTF3. g In
situ hybridization for btf3, twist, and n-cad in st24 embryos, arrows show neural crest and asterisk the eye. Scale bar= 50 μm. Note that btf3 and n-cad are
coexpressed in the migrating neural crest (identiﬁed by twist expression), and in the eye and neural tube. Summary of btf3, twist and n-cad expression
proﬁles. Histograms in c and e represent mean ± S.E. (in e one-way ANOVA p < 0.001, two-tailed t- test p** < 0.01, p*** < 0.001). N number of independent
experiments; n sample size. Spread of data in bar charts is shown as overlying dots. n.s. nonsigniﬁcant
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1mM EDTA, 1 mM EGTA, 1mM DTT, phosphatase and protease inhibitors) per
embryo. All samples were centrifuged at 250×g for 5 min to remove embryo debris.
After collecting the supernatant, it was distributed to three different tubes and spun
at three different speeds (400×g, 600×g) for 5 min to isolate the cell nuclei. The
postnuclear supernatants were kept for further processing. The nuclear pellets were
washed once more in buffer HG and centrifuged at the appropriate speed (400×g,
600×g). Nuclear pellets were then resuspended in 40 μL 10% glycerol/0.1% SDS/1%
Triton-X in HB. Appropriate amount of sample buffer was added to each sample,
and samples were processed for acrylamide gel electrophoresis and western blot
analysis. In order to avoid loading errors, the same membrane was blotted against
the loading control after stripping as described before54,64.
Western blot data were analyzed using ImageJ analysis tools. Image intensities
were normalized and the ratio of the protein of interest to loading control (i.e.,
Mapk or α-tubulin) was calculated, average ratios were plotted. Uncropped blots
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are included as supplementary ﬁgures (Supplementary Figs. 5–7). and
Supplementary Fig. 7)
Cell cultures. HeLa cells (Leibniz Institute Collections of Microorganisms and Cell
Culture, DSMZ, Germany) were cultured in DMEM supplemented with 10% fetal
calf serum (Life Technologies, CA, USA) at 37 °C in a humidiﬁed atmosphere of
10% CO2 and transfected as indicated using Rotifect (Carl Roth, Germany)
according to the manufacturer’s instructions.
Xenopus embryonic ﬁbroblasts (XTC, a kind gift from Ana Losada) were
cultured in 67% DMEM/H2O supplemented with 10% fetal calf serum at 25 °C in a
humidiﬁed atmosphere of 5% CO2 and transfected as indicated using Viafect
(Promega, USA). Plasmids for transfection were as indicated and 10–20 Hela or
XTC cells were analyzed for each condition per experiment.
For siRNA experiments, a combination of three siRNA targeted against BTF3
were transfected as described above. A standard siRNA (scrambled siRNA from
Sigma) was used as a control. Catalog number for these commercial siRNA against
BTF3 are: SASI_Hs01_00124567; SASI_Hs02_00308337; SASI_Hs01_00124566.
Cells were collected 48 h after transfection and processed for qPCR, western blot, or
Immunohistochemestry experiments. As described in the respective sections.
All cell lines were tested for mycoplasma contamination.
Immunohistochemestry and phalloidin staining. For protein detection, mam-
malian cells or neural crest explants were ﬁxed in 4% formaldehyde in 0.2% PBS-T
(PBS+ 0.2% Triton X-100) for 10-min and blocked with 10% NGS for 1 h. Primary
antibodies were incubated ON at 4 °C in 10% NGS. The following antibodies were
used: 1/100 anti-BTF3 (Abcam, ab107213), 2.5 µg/ml of anti-N-cadherin (MNCD2
Developmental Studies Hybridoma Bank), and 1:100 anti-Cx43 (Sigma, C6219) in
10% NGS and incubated ON at 4 °C. Explants were washed 3 times with PBS+
0.2% Tween-20 and incubated ON at 4 °C with secondary antibody, diluted at
1:350 in 10% NGS. DAPI was diluted at 1:1000 and mixed with the secondary
antibodies.
Mass spectrometry. For co-immunoprecipitation of the FLAG-tagged Cx43Tail
for mass spectrometric analysis cells were lysed and lysates were incubated over-
night with anti-HA and equilibrated high afﬁnity beads at 4 °C, the immunopre-
cipitates were then washed and eluted27. Subsequently of acid elution with 0.1 M
glycine pH 2.5, the pH of the eluates was adjusted to pH 8.0 with 0.5 M Tris. For
protein digestion samples were incubated overnight with 2 µg trypsin (Trypsin
Gold, Promega, USA) followed by addition of 0.1 µg Lys-C (Roche, Germany) and
incubation for additional 6 h. The peptides were desalted on C-18 reversed phase
stage tips (Nest Group, USA), dried in vacuum and stored at −20 °C until analysis.
Dried peptides mixtures were recovered in 3 µl 30% formic acid and diluted with
water to 23 µl. Five µl of the digest were injected on a Nano-LC system (Eksi-
gent425 2D Nano-LC; Sciex, USA) and peptides were separated by reversed phase
chromatography on C-18 columns prepared in-house (Reprosil-Pur C18-AQ, 1.9
µm, Dr. Maisch, Germany, PicoFrit Columns, 75 µm i.d., New Obejctive, USA) in a
linear gradient of 100% eluent A (0.1% formic acid) to 55% eluent B (60% acte-
nitrile, 0.1% formic acid) in 120 min. The LC-system was setup as vented column
and sample was load and desalted at a ﬂow rate of 400 nl/min and separation was
carried out at a ﬂow rate of 200 nl/min. The nano-LC system was hyphenated to
the mass spectrometer (Q-Exactive HF, ThermoScientiﬁc, Germany) which was
operated in data-dependent mode. Data interpretation was performed with Mascot
V2.2 (Matrixscience, UK) and Progenesis LC–MS V4.1 (Nonlinear Dynamics, UK).
Data interpretation was performed with MaxQuant V1.6.1.0 and Perseus V1.6.1.3
(MPI of Biochemistry, Germany).
Coupling assay. Gap junction intracellular communication was tested using a dye
coupling assay. Here, the ﬂuorescent dye Calcein-AM (Sigma, 17783) was used. A
neural crest population dissected from uninjected embryos was incubated with the
dye Calcein-AM for approximately 10 min or until the dye was loaded into all the
cells. Another neural crest population from embryos injected with a nuclear marker
(nRFP mRNA injections, see above) was dissected separately. After the two
populations were dissociated in absence of calcium and magnesium, they were
mixed and incubated for 1 h at 14 °C in a test tube. Following mild centrifuge, the
neural crest explants were cut in similar size pieces and cultured as described above
and then ﬁlmed. To test the channel activity of gap junctions, gap junction
blockers; meclofenamic acid (Sigma, M4531) and ﬂufenamic acid (Sigma, F9005)
were used. Cell communication was assessed by estimating the ratio of number of
cells that display both tracers, the nuclear marker and the Calcein to the total
number of cells that have the nuclear marker.
Statistical analysis. The estimation of the sample size was done by following
previously published work and no speciﬁc statistical method was used. Experiments
were not randomized and due to the nature of the experiments, the authors were
not blinded to allocation during both, experiments and results analysis. Only viable
embryos and explants were analyzed. Mis-injected embryos were not included for
in situ hybridization experiments. Correct injection was determined by injection of
linear tracers. Our experimental parameters were measured at random once viable
and properly injected embryos were selected.
Comparison of percentages was performed using contingency tables66.
Normality of data sets was tested using Kolmogorov–Smirnov’s test, d’Agostino
and Pearson’s test and Shapiro–Wilk’s test using Prism6 (GraphPad). Datasets
following normal distribution were compared with Student’s t- test (two-tailed,
unequal variances) or ANOVA with a Dunnett’s multiple comparisons post-test
using Excel or Prism6 (GraphPad). Datasets that did not follow a normal
distribution were compared using Mann Whitney’s test or a nonparametric
ANOVA (Kruskal Wallis with Dunn’s multiple comparisons post-test) using Excel
or Prism6. Cross-comparisons were performed only if the overall p value of the
ANOVA was less than 0.05. In all ﬁgure legends N= number of independent
experiments; n= total sample size.
X. laevis n-cadherin partial promoter identiﬁcation. To identify the basic pro-
moter of Xenopus n-cad we used the following strategy. The basic promoter
region from chick and mammalian n-cadherin genes have been described at the
5′-UTR regions, within the position −3000 to −1 bp respect the translation
initiation site41,67. By using the X. laevis Genome Project resource (https://
xenopus.lab.nig.ac.jp/) we identiﬁed a region of 2800 bp in the 5′-UTR of the X.
laevis n-cadherin gene (Supplementary Fig. 4). Since our data indicate that
Cx43Tail, BTF-3, and Pol II form a complex, we use ElemeNT tool68 to search for
potentially active TATA boxes in the region that we isolated. Our in silico ana-
lysis reveal a TATA box rich region between the positions −166 to −618 bp,
relative to the translation start site (Supplementary Fig. 4). Finally, we design
overlapping primers to amplify fragments of 200 bp across this region. Primers
sequences are listed in the ChIP section and their binding regions are highlighted
in Supplementary Fig. 4.
Chromatin immunoprecipitation (ChIP). For chromatin immunoprecipitation
(ChiP), we followed a standard procedure for X. laevis embryos69,70. For each
independent experiment we used two technical replicas and 250–300 Xenopus
embryos per condition. Brieﬂy, neurula stages X. laevis embryos were ﬁxed for
15 min and 3 μg of Pol II antibody (Diagenode, C15100055) or GFP ChIP grade
antibody (Abcam, ab290) were used. For DNA extraction we followed a standard
protocol69,70. Using the ElemeNT analysis resource, we searched for putative
TATA boxes in the X. laevis n-cad promoter region (Supplementary Fig. 4). Pri-
mers ﬂanking these TATA boxes were designed to analyze ChiP samples by PCR.
Fig. 8 Cx43 carboxy-terminal is recruited to the nucleus by BTF3. a St24 embryos showing neural crest migration by ISH of twist. Arrowheads show normal
and brackets impaired migration. Asterisk indicates the eye. Scale bar= 40 μm. b Neural crest migration index for the indicated treatment. (nCMO= 89,
nBTF3MO= 98, nBTF3MO-BTF3FL= 105, N= 4. c Lateral view of embryos at st24 showing n-cad expression, analyzed by ISH. Arrows show normal and brackets
impaired expression, asterisk indicates the eye. d % of n-cad expressing embryos shown in c (nCMO= 92, nBTF3MO= 127, nbtFL+BTF3MO= 98 embryos, N=
4). e Analysis of N-cadherin expression in blastulae embryos (st9). Scale bar= 30 μm. f n-cad expression levels, representative embryos in e (nCMO= 56,
nCx-20k= 112, nCx-20k-BTF3MO= 88 embryos, N= 4). g Temporal analysis of Cx43-20k-GR nuclear localization in st23 neural crest after addition of dxm
(time is shown in minutes after dxm treatment). Cx43-20k-GFP is shown in color-coded intensity and n-RFP is used to visualize the nucleus. Graph shows
Cx43-20kGR-GFP nuclear ﬂuorescence normalized to the cytosolic ﬂuorescence (nCMO= 25, nBTF3MO= 32 explants, N= 3). h St23 neural crest, showing
color-coded intensity of Cx43-20k-GFP compared with nRFP to visualize nuclear localization. In red diagrams BTF3 NLS deletion constructs are shown.
Chart of nucleus vs. cytosol ratio of Cx43-20k-GFP (nCMO= 25, nBTF3MO= 39, nBTF3MO-btf3= 58, nBTF3MO-btf3ΔNLS= 58, N= 3 independent experiments).
Scale bars in g and h= 20 μm. In b box plots show the median, box edges represent the 25th and 75th percentiles, and whiskers show spread of data
including outliers (Mann Whitney test p*** < 0.001). Histograms in d, f, h, and lines in g represent mean and error bars S.E. (one-way ANOVA; p < 0.001;
two-tailed t test p** < 0.01, p*** < 0.001. N number of independent experiments; n sample size. Spread of data in bar charts is shown as overlying dots. n.s.
nonsigniﬁcant
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PCR was performed using the following protocol 95 °C for 30 s, 56 °C for 40 s, and
72 °C for 30 s for 32 cycles. Primers used for ChiP-PCR were:
P5F: 5′-CTTCCAAGAGATGAAGCTCATAT-3′,
P5R: 5′- AACACTCTATATGGCAGATAAC-3′,
P6F: 5′-CCTTTAAATGCATACACTTACC-3′,
P6R: 5’-ACAGAAAAAGCATTTGCTTCCT-3′,
P7F: 5′-CAATCAGATCCTTATATGTCCC-3′,
P7R: 5′-GCCAAGTTTTCCCTTTGTTGT-3′,
P8F: 5′-GGAAGCAAATGCTTTTTCTGTC-3′,
P8R: 5′-AGTCTGCTTTAGGAGACAACG-3′
and their relative binding sites are shown in Supplementary Fig. 4b. ChIP
experiments were quantiﬁed as follow: normalized ratio of band intensity for
each condition was averaged it and the fold increase respect the IgG control was
calculated and plotted as fold enrichment. Band intensity was registered by using
ImageJ Gels analysis plugin. Uncropped gels are shown in Supplementary
Fig. 7c, d.
Data availability
All data and custom codes are available upon reasonable request to the corresponding
author. The mass spectrometry proteomics data have been deposited to the Proteo-
meXchange Consortium via the PRIDE partner repository with the dataset identiﬁer
PXD010870
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